Maria Febe Solari Email & Phone Number

I began my career as an academic intern for GEF Company, at the Caracas, Venezuela branch office, with head office in New York and later moved to the position of Director of Legal and Commercial Public affairs for the Caracas branch office. In 2005 – 2009 Aurora Productions Ltd Inc. based in Switzerland, extended a career training opportunity at their Bangkok branch, shortly after I moved to the Taiwan branch as Creative Director for Digital Productions until 2009.In 2011, I joined FAIMS Media as an international consultant Business Development Director for its overseas accounts, delivering results in high-growth and solidifying market-leadership accounts, and with limited resources I successfully established the FAIMS Media operation teams in Singapore & Thailand in under a year. I specialized in re-structuring operational, production methods and budget spending. I spearheaded the Technology & Innovation Department and I was responsible for developing strategic partnerships and our regional business plan & strategy for all assets across the region.In 2013 my sister in-law passed away from a rare form of leukemia, and the experiences lived through that ordeal led me to switch fields, and in 2014 I both co-founded PT WSM Ventures Indonesia. PT WSM Ventures Indonesia is the holding company of the ARC MEDISPA Brand. In December 2018 I received a 2 million USD investment to co-found PT. Inti Sehat Prima. PT. Inti Sehat Prima is a holding company for the collaboration with Singapore company Bloommed Group Pte. Ltd. to establish locally a Bloommed Lab and manufacture MDSC and ISC Therapy in Indonesia. MDSC and ISC is an autologous mononuclear cell therapy for degenerative and chronic debilitating conditions such as SLE, Multiple-Sclerosis, post-chemotherapy, etc. and it is the first cell therapy of its kind to be insured.In 2019 I completed my CRISPR Gene Editing Applications course with Harvard. And in early 2020 I Co-founded PT Fokus Keluarga Sehat who purchased PT. Inti Sehat Prima and invested another 3.3 Million USD to further my work in PT Fokus Keluarga Sehat with MDSC/ISC Therapy, IVD tools and modeling applications of CRISPR technology.Early 2020 I also partnered with Vazyme Biotech in China, one of the fastest growing Enzyme NGS Libraries in the world, and together I hope to expand R&D for IVD tools via SOLARI Biotech Pte. Ltd.I am also a constant and active advocate of humanitarian-aid and social-responsibility efforts, and to-date 21 countries have benefited from my not-for-profit work.